Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Tranexamic Acid Powder with CAS 1197-18-8

CAS:1197-18-8
其他名称:凝血酸
MF:C8H15NO2,C8H15NO2
EINECS No.:214-818-2

Synonyms: TIMTEC-BB SBB006715; TRANS-4-AMINOMETHYL-1-CYCLOHEXANECARBOXYLIC ACID; trans-4-aminomethylcyclohexane-1-carboxylate

Tranexamic Acid Powder with CAS 1197-18-8
填好这个现场
请输入有效的电子邮箱地址。
填好这个现场
填好这个现场
填好这个现场
你需要同意这些条款进行

what is of Tranexamic Acid with CAS 1197-18-8?

Tranexamic Acid with CAS 1197-18-8 is a synthetic derivative of lysine. It is a commonly used hemostatic agent in clinical practice. It plays a hemostatic effect by inhibiting the dissolution of fibrin. Trantranic acid can strongly adsorb Lysine-binding sites of fibrinogen affinity sites on plasminase and plasminogen, and inhibit the binding of plasminogen and fibrin, and thus strongly inhibit the decomposition of fibrin caused by plasminogen. In addition, the antifibrinolytic effect of tranatemic acid was more obvious in the presence of antifibrinolytic enzymes such as macroglobulin in serum

规格 

项目  测试 标准 作为  USP30
 

 

描述

1.白色晶状粉末、无味和有苦味
2.自由溶于水和冰醋酸;非常微溶解乙醇中;实际上不溶于醚
3.溶解在氢氧化钠TS
 

 

识别

1.Nimhydrin反应产生深紫色的
2.干燥的沉淀物形成有

p-甲苯磺酸化之间的265.0℃-266.0℃

清楚的  解决方案 清楚和无色
氯化 ≤0.014%
 金属 ≤10ppm
≤22ppm
容易 碳化 立场 没有颜色的发展
独联体异构体 ≤0.8%
损失  干燥 ≤0.5%
残留物  点火 ≤0.10%
测定 ≥99.0%的C₈H1sNo₂(干)

使用 

凝血酸是一种合成衍生物赖氨酸,这是一个纤维蛋白溶解的药物和具有止血性

止血剂有重大影响的创伤性出血,和预防性药物治疗手术前可以降低外科手术出血

包装

25公斤/鼓9tons/20'container
25公斤/袋,20tons/20'container

Tranexamic Acid with CAS 1197-18-8-PACKAGE

Tranexamic Acid Powder with CAS 1197-18-8
填好这个现场
请输入有效的电子邮箱地址。
填好这个现场
填好这个现场
填好这个现场
你需要同意这些条款进行

你也可以喜欢